MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q2 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,762,000 | +12.5% | 207,419 | +34.5% | 0.36% | +11.6% |
| Q1 2019 | $5,121,000 | -8.4% | 154,246 | -15.5% | 0.32% | +26.0% |
| Q2 2016 | $5,588,000 | -26.8% | 182,606 | -10.5% | 0.25% | -26.6% |
| Q1 2016 | $7,633,000 | -14.5% | 203,916 | -1.5% | 0.35% | -14.1% |
| Q4 2015 | $8,932,000 | +40.5% | 206,952 | +22.0% | 0.40% | +38.0% |
| Q3 2015 | $6,357,000 | -29.7% | 169,616 | -49.6% | 0.29% | -18.7% |
| Q2 2013 | $9,049,000 | – | 336,784 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |